INTERNATIONAL JOURNAL OF STD & AIDS is a prominent publication dedicated to advancing the understanding and treatment of sexually transmitted diseases and HIV/AIDS. Published by SAGE Publications Ltd, this esteemed journal has been contributing to the medical community since 1990, with a convergence of studies spanning to 2024. With its ISSN 0956-4624 and E-ISSN 1758-1052, the journal is recognized for its rigorous peer-reviewed research and has successfully positioned itself in the second quartile (Q2) of Dermatology and Public Health, alongside notable rankings in Infectious Diseases and Pharmacology. Currently based in the United Kingdom, this journal serves as a crucial resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and critical reviews that address global health challenges. Although it does not offer Open Access, the journal continues to maintain its reputation as a vital reference point for those invested in the fields of dermatology, public health, and infectious diseases.

Journal of the International Association of Providers of AIDS Care, published by SAGE PUBLICATIONS INC, is a distinguished open-access journal dedicated to the field of HIV/AIDS care and research. Since its inception in 2002, the journal has provided an essential platform for the dissemination of high-quality, peer-reviewed scholarly articles that advance knowledge in exciting areas such as dermatology, immunology, and infectious diseases. With an impact factor that highlights its role in shaping ongoing discourse, the journal boasts a strong reputation, reflected in its Q1 status in Dermatology and consistent ranking in the top tiers for immunology and infectious diseases in the Scopus Ranks. This commitment to excellence ensures that researchers, healthcare professionals, and students have access to the latest advancements and best practices in HIV/AIDS prevention and care. As a pivotal resource in the global health landscape, the journal stands at the forefront of efforts to combat the challenges presented by this ongoing epidemic.

JOURNAL OF TROPICAL PEDIATRICS, published by Oxford University Press, stands as a critical platform for the dissemination of research and clinical advancements in the field of tropical pediatrics. With a rich history dating back to 1955, this journal serves as a significant contributor to our understanding of health issues affecting children in tropical and subtropical regions, focusing on infectious diseases, pediatric care, and child health. It currently holds an impressive Q2 ranking in three categories: Infectious Diseases, Medicine (miscellaneous), and Pediatrics, Perinatology and Child Health, placing it among the top journals in its field. Featuring both formative research and applied studies, the journal aims to address the unique challenges posed by pediatric care in tropical environments. Its inclusion in an esteemed database ensures a broad dissemination of critical knowledge to researchers, healthcare professionals, and students alike, promoting a collaborative approach to improving child health outcomes globally.

JAIDS - Journal of Acquired Immune Deficiency Syndromes, is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamics of HIV/AIDS and its broader implications in the fields of infectious diseases and pharmacology. With an esteemed impact factor that places it in the prestigious Q1 category for both Infectious Diseases and Pharmacology (medical) as of 2023, this journal aims to provide a platform for groundbreaking research, clinical findings, and innovative therapies relevant to the management and prevention of HIV/AIDS. The journal's rigorous editorial standards and commitment to advancing knowledge make it an essential resource for researchers, healthcare professionals, and students invested in the global response to AIDS. Although the journal does not currently offer open access options, it remains instrumental in disseminating high-quality research that shapes clinical practices and policy developments in the field.

Current HIV/AIDS Reports, published by Springer, is a distinguished scholarly journal that addresses critical developments in the field of HIV/AIDS research. As a leading publication within the Q1 quartiles for both Infectious Diseases and Virology, it serves as an essential platform for researchers and healthcare providers aiming to advance knowledge and practices related to HIV prevention, treatment, and care. With a commitment to publishing innovative studies, reviews, and clinical guidelines, this journal fosters a comprehensive understanding of the complexities surrounding HIV/AIDS. The journal enjoys a robust reputation, evidenced by its impressive Scopus rankings, including a rank of #69 in Infectious Diseases and #21 in Virology, placing it in the top echelons of its field. With an open-access model, *Current HIV/AIDS Reports* significantly enhances the accessibility of crucial research findings to a global audience, driving progress in HIV/AIDS knowledge and public health.

Journal of HIV-AIDS & Social Services is a pivotal academic platform committed to advancing the understanding and management of HIV-AIDS through the lens of social services. Published by Routledge Journals, Taylor & Francis Ltd, this journal spans significant years from 2002 to 2024, making it a key resource for the latest research and practices in the intersecting fields of health and social sciences. With an ISSN of 1538-1501 and an E-ISSN of 1538-151X, the journal holds a respectable position within the academic community, marked by its categorization in the Q3 quartile of both Health (Social Science) and Infectious Diseases as of 2023. The journal strives to provide a forum for innovative research addressing the complexities of HIV-AIDS, incorporating perspectives from various stakeholders, including healthcare providers, policymakers, and community organizations. Although it currently does not offer open access options, its indexed presence and dedicated readership ensure the dissemination of vital knowledge in a field that is more critical than ever. For researchers, professionals, and students dedicated to combating HIV-AIDS, this journal serves not just as a publication, but as a catalyst for change in global health initiatives.

AIDS, published by Lippincott Williams & Wilkins, stands as a premier journal within the fields of immunology and infectious diseases, reflecting a distinguished history since its inception in 1987 and offering insights that shape contemporary research and practice. With an impressive impact factor and categorized in the Q1 quartile across critical areas including Immunology, Infectious Diseases, and Immunology and Allergy, the journal showcases high-quality, peer-reviewed articles that consistently contribute to the advancement of knowledge and innovation in the fight against AIDS and related conditions. Researchers and professionals will find its content invaluable, as it brings forth groundbreaking studies, novel therapeutic approaches, and comprehensive reviews that inform both clinical practices and public health policies. Although not an open access journal, it remains a vital resource for those committed to addressing one of the most pressing global health challenges of our time.

The Journal of the International AIDS Society, published by John Wiley & Sons Ltd, stands as a premier platform for advancing knowledge in the realms of infectious diseases and public health, boasting a strong Q1 ranking in both categories as of 2023. With its open-access format established since 2004, the journal ensures that groundbreaking research on HIV/AIDS and related issues is widely disseminated and easily accessible to a global audience. This commitment to accessibility significantly enhances its impact factor, making it a vital resource for researchers, practitioners, and students alike who are dedicated to improving health outcomes and understanding the complexities of the epidemic. Covering a diverse range of topics from prevention strategies to health policy, the journal supports its readers in staying at the forefront of public health discourse. With its base in the United States and an impressive Scopus ranking placing it within the top tiers of medical publications, the Journal of the International AIDS Society continues to foster collaboration and innovation in the fight against HIV/AIDS.

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

AIDS Research and Therapy is a prestigious peer-reviewed journal dedicated to disseminating cutting-edge research in the fields of AIDS and HIV therapy. Published by BMC, this Open Access journal has been freely available since its inception in 2004, facilitating global access to vital research findings. Based in the United Kingdom, the journal covers a diverse range of topics including molecular medicine, pharmacology, and virology, making it a crucial resource for researchers and clinicians alike. Recognized for its strong impact within the scientific community, it holds a Q2 quartile ranking in multiple categories as of 2023, including Molecular Medicine and Pharmacology. With an aim to enhance understanding and improve clinical outcomes for those affected by HIV/AIDS, AIDS Research and Therapy serves as an essential platform for the exchange of innovative ideas and practices that can inform future therapies and interventions. Researchers, professionals, and students seeking high-quality, peer-reviewed content will find this journal invaluable in advancing their knowledge and efforts in combating the HIV/AIDS epidemic.